View all Podcasts
Health FDA Reform, Pharmaceuticals
November 21st, 2011 Podcast

Paul Howard and former FDA Commissioner, Dr. Andrew C. von Eschenbach, discuss the FDA's recent decision revoking Avastin's approval for the treatment of metastatic breast cancer

Table of Contents

Paul Howard and former FDA Commissioner, Dr. Andrew C. von Eschenbach, discuss the FDA's recent decision revoking Avastin's approval for the treatment of metastatic breast cancer.

Previous Episodes

- - -
-
-

-

- - -
-
-

-

- - -
-
-

-